I]EGF binds to the 170 kDa receptor and Scatchard plot analysis shows high affinity and low affinity KC,S of 1.7 ΠΜ and 24 ΠΜ, respectively, in whole cells, and 0.2-0.8ΠΜ and 39-116nM, respectively, in isolated non-phosphorylated membrane fractions. We have estimated the presence of 48 χ 10 3 high affinity and 275 x10 3 low affinity EGF binding sites per tumor cell. Phosphoamino acid analysis shows EGFdependent phosphorylation of tyrosine and serine residues. A polyclonal antibody to a human EGF receptor/c-eroB-2 product common cytoplasmic domain epitope immunoprecipitates a 45 kDa phosphopolypeptide from the tumor membrane fractions and from whole cell lysates. Phosphoamino acid analysis of the immunoprecipitated 45 kDa phosphopolypeptide shows the presence of phosphoserine. The immunoprecipitated 45 kDa polypeptide is able to undergo EGF-independent phosphorylation, although no significant protein kinase activity towards exogenous substrates is detected.
The epidermal growth factor (EGF) is involved in proliferation and differentiation processes in many cell types after binding to a receptor located in the plasma membrane (Carpenter, 1987; Maihle and Kung, 1988) . Binding of EGF to its receptor results in a series of sequential signal transduction events leading to mitosis (Hunter and Cooper, 1981; Cohen et a/., 1982; Bertics and Gill, 1985; Moolenaar et a/., 1986; Pandiella et a/., 1988) .
The number of EGF receptors varies in different cells and in a given cell type under different physiological conditions. Cellular transformation can result from significant alterations in the levels of expression of this receptor. For instance, overproduction of the human EGF receptor in NIH 3T3 fibroblasts results in a ligand-dependent expression of the transformed phenotype (Di Fiore et a/., 1987) . Also, a large number of EGF receptors has been detected in some tumor cell types, as it is the case in the human epidermoid carcinoma A431 cell line (Ullrich ef a/., 1984) . In addition, human hepatoma cell lines exhibiting different degrees of dedifferentiation have been found to express variable numbers of high-and low-affinity EGF receptors (Clementi et a/., 1989) . In some tumors, the expression of truncated analogs of the normal EGF receptor appears to be involved in cellular transformation (Carpenter, 1987) . These tumor cells are in general able to grow independently of mitogenic polypeptide signals.
The presence of EGF receptors has been previously noticed in Ehrlich ascites tumor cells (Usui et a/., 1985) . However, their properties were not studied in detail. In this communication we present a comprehensive characterization of the EGF receptor from this tumor cell line. In addition, we demonstrate the presence of a membrane-associated 45 kDa phosphopolypeptide that immunoprecipitates using an antibody directed against a human EGF receptor/c-ert>B-2 product common epitope.
Ehrlich ascites tumor cells exhibit a high rate of [methyl· 3 H]thymidine incorporation into DMA in the absence of EGF (with or without insulin) or fetal calf serum (FCS) added to the medium, in contrast to non-transformed Swiss 3T3 mouse fibroblasts which require either EGF plus insulin or FCS to grow (results not shown). The absence of EGF-mediated stimulation of the already high rate of [me#7y/-3 H]thymidine incorporation into DMA of Ehrlich ascites tumor cells raises the possibility that this tumor cell line harbors an altered EGF receptor or have an impairment in the EGF-mediated signal transduction pathway. Thus, with the aim of testing whether EGF induces or not phosphorylation of its pressumptive receptor we carried out phosphorylation experiments in isolated membrane fractions, in the absence and presence of EGF. Figure 1 Figure 1 an apparent affinity constant for EGF in the range of 40-50 nM was calculated. Transforming growth factor α (TGFa) was also found to stimulate the phosphorylation of the 170 kDa polypeptide, its apparent affinity constant for this ligand being in the same range (results not shown).
The EGF-dependent phosphorylation of the 170 kDa polypeptide was partially resistant to alkali treatment (0.5M NaOH, 1 h at 55°C), suggesting that phosphotyrosine residues were present in the 170 kDa phosphopolypeptide (Cooper et a/., 1983) . In agreement with this observation, phosphoamino acid analysis of the 170 kDa protein showed an EGF-dependent phosphorylation of tyrosine residues (Figure 2 ). Phosphoserine was also detected in basal conditions, and its level increased in the presence of EGF (Figure 2 ). An EGF-stimulated phosphorylation of tyrosine and serine residues has been shown by us to take place as well in an isolated EGF receptor preparation from normal rat liver (San Jose ef a/., 1992).
A phosphorylation time-course analysis of the 170 kDa polypeptide from Ehrlich ascites tumor cells showed that maximum levels of phosphorylation were attained in the presence of EGF 1 min after the addition of [γ-32 Ρ]ΑΤΡ. After this rapid incorporation of phosphate a progressive dephosphorylation was observed, 50-70% of the labeling being lost within the first thirty minutes of reaction (results not shown). A phosphotyrosyl-directed protein phosphatase has been purified from Ehrlich ascites tumor cell lysates (H rlein et a/., 1982) . This enzyme is inhibited by zinc ion and is distinct from alkaline phosphatase. A similar phosphotyrosyl-directed protein phosphatase has been described in A431 cell membrane vesicles. Furthermore, this enzyme has been shown to dephosphorylate the EGF receptor (H rlein ei a/., 1982). We have tested the effect of Zn 2+ on the phosphorylation levels of the 170 kDa polypeptide, and found that this cation did not significantly affect its phosphorylation rate, though it efficiently prevented its dephosphorylation in the absence as well as in Figure 1 , in the absence or presence of 1μΜ EGF. After electrophoretic separation, the phosphorylated 170 kDa band was cut from the dried gel and processed for phosphoamino acid analysis (Hunter and Sefton, 1980 Table 1 summarizes the values estimated from Scatchard plot analyses for the high and low affinity constants of [ 125 I]EGF for its receptor, as well as for the number of receptors present in whole cells and isolated membrane preparations. Values obtained in isolated membranes for the high affinity K^ were in the range of 0.2-0.8 ΠΜ, and for the low affinity K^ in the range of 39-116nM. Estimated numbers of 0.2-2.5 χ 10 11 and 6-28 χ 10 11 receptors per mg of membrane protein were found for the high-and the low-affinity receptors, respectively. In whole cells the calculated high affinity Κ ύ was 1.7 ΠΜ, and the low affinity Κ ύ was 24nM. Ca. 48 χ 10 3 and 275 χ 10 3 high-and low-affinity receptors, respectively, were also estimated to be present per cell. In comparison to other cell lines, the number of high-affinity EGF receptors found in Ehrlich ascites tumor cells (48 χ 10 3 ) is lower than the number of high affinity receptors expressed by the human epidermoid carcinoma A431 cells (0.2-0.4 χ 10 6 ) (Lokeshwar et a/., 1989) . Also, the total number of receptors (high-and low-affinity) in Ehrlich ascites tumor cells (0.3 χ 10 6 ) is lower than in NIH 3T3 fibroblasts overexpressing the human EGF receptor (0.3-4 x10 6 ) (Di Fiore etal., 1987; Pandiella etal., 1988) , although higher than in human fibroblasts (40-100 χ 10 3 ) or untransfected NIH 3T3 fibroblasts (3 χ 10 3 ) (Carpenter etal., 1975; Di Fiore etal., 1987) . Figure 1 , in the absence (-) or presence (+) of 1 μΜ EG F. Thereafter, the samples were solubilized with 1 % (w/v) Triton X-100 and processed for electrophoresis and autoradiography before (lanes 1 and 2) and after (lanes 3 and 4) immunoprecipitation with the antibody mentioned in the text. Arrows point to the 170 kDa EGF receptor from EGFR T17 fibroblasts (panel A), and to the 45 kDa phosphopolypeptide from Ehrlich ascites tumor cells (panel B). Table 1 EGF Binding Parameters of the EGF Receptor from Ehrlich Ascites Tumor Cells. Ehrlich ascites tumor cells were incubated for 2 h at 37°C in 100 ml of FCS-free RPMI-1640 medium containing 20 mM Na-Hepes (pH 7.4) and 0.1 % (w/v) bovine serum albumin (BSA). After being washed, the cells (2.1 χ 10 6 ) were incubated at 4°C for 4 h in 550 μΐ of the above medium containing 2 ΠΜ (0.15 μΟ\) [ 125 I]EGF, and different concentrations of non-radiolabeled EGF up to 1 μΜ. The cells were then washed, and solubilized in 0.5 ml of 0.4M NaOH, and the extracted radioactivity was measured with a γ-ray counter. Alternatively, membrane fractions (200 μg of protein) were incubated at 23°C for 1 h in 200μΐ of 20 mM Na-Hepes (pH 7.4), 0.1 % (w/v) BSA, containing 2nM (0.1 μΟ) [ 125 I]EGF and different concentrations of non-radiolabeled EGF up to 1 μΜ. The reaction mixtures were diluted thereafter with 2 ml of 20 mM Na-Hepes (pH 7.4), 0.1 % (w/v) bovine serum albumin (BSA) washed, and fast filtrated through Whatman glass microfibre filters, the associated radioactivity being measured as above. We performed immunoprecipitation experiments using an antibody directed to a common epitope shared by the intracellular domains of the human EGF receptor and the product of the c-erbB-2 gene (residues 929-947 of the c-erbB-2 product) (Yamamoto et a/., 1986) . Cell lysates and solubilized membrane fractions from Ehrlich ascites tumor cells were subjected to immunoprecipitation using as a control cell lysates of EGFRT17 fibroblasts, a cell line overexpressing the human EGF receptor (Pandiella et a/., 1988) . 1 and 2) .The 170 kDa EGF receptor was clearly detected in immunoprecipitates from EGFRT17 fibroblasts, although no polypeptide of comparable molecular mass was detected in Ehrlich ascites tumor cells. However, a 45 kDa phosphopolypeptide was immunoprecipitated from the solubilized Ehrlich ascites tumor cell membrane fraction. No significant effect was observed to be exerted by EGF on the phosphorylation level of this 45 kDa phosphopolypeptide. The phosphorylation pattern of the isolated membrane fractions from Ehrlich tumor cells showed that the 45 kDa phosphopolypeptide is a prominent component of the membranes of these tumor cells. This protein is also immunoprecipitable from Ehrlich tumor cell lysates (results not shown).
Phosphoamino acid analysis of the 45 kDa phosphopolypeptide immunoprecipitated from Ehrlich ascites tumor cells showed the presence of phosphoserine as the only phosphorylated amino acid (results not shown). This polypeptide was able to undergo phosphorylation after its immunoprecipitation, suggesting that autophosphorylation or, alternatively, phosphorylation by a co-immunoprecipitated protein kinase was taking place.
Truncated analogs of the normal EGF receptor such as the v-enbB oncogene product from the avian erythroblastosis virus, or the activated c-erbB oncogene product from the avian leucosis virus exhibit high sequence homologies to sections of the normal EGF receptor, but lacking most of their extracellular ligand binding domains (Carpenter, 1987) . These truncated EGF receptor variants display hyperactive tyrosine kinase activity. In contrast, the 45 kDa phosphopolypeptide immunoprecipitated from Ehrlich ascites tumor cells is not phosphorylated in tyrosine residues, and protein kinase activity towards exogenous substrates, such as casein, histone and poly-L-[Glu:Tyr] (a copolymer of L-glutamic acid and L-tyrosine), was not detected (results not shown). Furthermore, this phosphoprotein exhibits a lower molecular mass than the above mentioned truncated forms of the EGF receptor.
Though the nature of the immunoprecipitated 45 kDa serine-phosphopolypeptide from Ehrlich ascites tumor cells is not currently known, several hypotheses can be raised. One possibility is that this phosphopolypeptide were a natural EGF receptor variant lacking tyrosine kinase activity, and its extracellular ligan-binding domain. Alternatively, the 45 kDa phosphopolypeptide could be a nonrelated protein sharing (a) common epitope(s) with the EGF receptor. Further work needs to be performed to elucidate whether this phosphopolypeptide has, if any, a role in cell proliferation, and if it bears any structural or functional analogy to the EGF receptor.
